Steward Partners Investment Advisory, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,508
-24.7%
2050.0%0.00%
Q2 2023$7,310
+27.9%
205
-8.9%
0.00%
Q1 2023$5,715
-37.4%
2250.0%0.00%
Q4 2022$9,126
-24.0%
225
-40.0%
0.00%
Q3 2022$12,000
-7.7%
3750.0%0.00%
Q2 2022$13,000
-23.5%
3750.0%0.00%
Q1 2022$17,000
-32.0%
3750.0%0.00%
Q4 2021$25,000
-19.4%
375
-25.0%
0.00%
-100.0%
Q3 2021$31,0005000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders